Alnylam Pharmaceuticals
Healthcare, Pharmaceuticals, and Biotech
Company Overview
Alnylam Pharmaceuticals is a US-based biopharmaceutical company that is dedicated to developing innovative RNA-based drugs for the treatment of genetic diseases. Founded in 2002, the company has become a leader in the field of RNAi therapeutics, a groundbreaking technology that targets the underlying genetic causes of diseases. Alnylam's pipeline of medicines includes treatments for conditions such as alpha-1 antitrypsin deficiency, acute hepatic porphyrias, and hereditary ATTR amyloidosis. The company is headquartered in Cambridge, Massachusetts, and has operations in Europe and Asia, with a workforce of over 1,000 employees. Alnylam is committed to transforming the lives of patients with rare genetic diseases through its pioneering RNAi platform.
Email Formats
Discover the email patterns used at Alnylam Pharmaceuticals to connect with the right people.
| Email Format | Example | Percentage |
|---|---|---|
| firstname.lastname@company.com | john.doe@company.com | 45% |
| firstname@company.com | john@company.com | 30% |
| firstinitial.lastname@company.com | j.doe@company.com | 15% |
| firstname_lastname@company.com | john_doe@company.com | 10% |
View Email formats of the company.
Email Verification Tool
Get verified email addresses of any IBM employee. Enjoy 100 free lookups every month.
